Nepsis Inc. Viking Therapeutics, Inc. Transaction History
Nepsis Inc.
- $674 Million
- Q4 2024
A detailed history of Nepsis Inc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Nepsis Inc. holds 19,376 shares of VKTX stock, worth $659,752. This represents 0.12% of its overall portfolio holdings.
Number of Shares
19,376
Previous 177,714
89.1%
Holding current value
$659,752
Previous $11.3 Million
93.08%
% of portfolio
0.12%
Previous 2.79%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
470Shares Held
63.2MCall Options Held
5.76MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$346 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$205 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$159 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$72.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$63.8 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.61B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...